Hennion & Walsh Asset Management’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.52M | Sell |
|
|||||
|
2025
Q2 | $3.23M | Sell |
|
|||||
|
2025
Q1 | $4.75M | Sell |
|
|||||
|
2024
Q4 | $5.57M | Sell |
|
|||||
|
2024
Q3 | $5.29M | Buy |
|
|||||
|
2024
Q2 | $3.96M | Buy |
|
|||||
|
2024
Q1 | $3.77M | Buy |
|
|||||
|
2023
Q4 | $3.07M | Buy |
|
|||||
|
2023
Q3 | $920K | Buy |
|
|||||
|
2023
Q2 | $349K | Sell |
|
|||||
|
2023
Q1 | $1.02M | Sell |
|
|||||
|
2022
Q4 | $1.73M | Buy |
|
|||||
|
2022
Q3 | $1.27M | Sell |
|
|||||
|
2022
Q2 | $218K | Sell |
|
|||||
|
2022
Q1 | $614K | Buy |
|
|||||
|
2021
Q4 | $521K | Buy |
|
|||||
|
2021
Q3 | $639K | Buy |
|
|||||
|
2021
Q2 | $630K | Buy |
|
|||||
|
2021
Q1 | $674K | Buy |
|